MO Committee Drug Costs

A new Missouri Senate committee is reviewing ways to lower healthcare costs. Lawmakers in the first meeting of the new interim committee heard from key stakeholders involved in the healthcare industry. The committee will cover a variety of health care issues related to hospitals, pharmacies, insurance companies, drug makers and other healthcare providers. Jorgen (yorgen) Schlemeier (SCHLAY-myer), a registered lobbyist focusing on healthcare says that Pharmacy Benefit Managers are the reason prescription drug prices are high…

[mo2prices1] :17 “the transaction”
He looked at over 40 different studies.